CRBU

Caribou Biosciences Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth↓ 0/10
  • Value↓ 0/10
Caribou Biosciences sales and earnings growth
CRBU Growth
Low
  • Revenue Y/Y↑ 11.66%
  • EPS Y/Y↓ 3.64%
  • FCF Y/Y↑ 21.47%
Caribou Biosciences gross and profit margin trends
CRBU Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↓ -1327.40%
  • ROIC 5Y↓ -45.90%
Caribou Biosciences net debt vs free cash flow
CRBU Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.1
  • Interest coverage↑ 999.0

Caribou Biosciences stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗